(+)-dexrazoxane multiple interactions ISO RGD:1323437 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in increased expression of GADD45G mRNA] CTD PMID:28973540 (1->4)-beta-D-glucan multiple interactions ISO RGD:1323437 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GADD45G mRNA CTD PMID:36331819 (S)-colchicine increases expression EXP 6480464 Colchicine results in increased expression of GADD45G mRNA CTD PMID:20624997 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane increases expression ISO RGD:1323437 6480464 2 more ... CTD PMID:20826375 1,1-dichloroethene decreases expression ISO RGD:1323437 6480464 vinylidene chloride results in decreased expression of GADD45G mRNA CTD PMID:26682919 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of GADD45G mRNA CTD PMID:21983209 17alpha-ethynylestradiol multiple interactions ISO RGD:1323437 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GADD45G mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of GADD45G mRNA CTD PMID:16174780 , PMID:17351261 17alpha-ethynylestradiol increases expression ISO RGD:1323437 6480464 Ethinyl Estradiol results in increased expression of GADD45G mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1323437 6480464 Ethinyl Estradiol affects the expression of GADD45G mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:1323437 6480464 Estradiol results in increased expression of GADD45G mRNA CTD PMID:19484750 more ... 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of GADD45G mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:1323436 6480464 Estradiol results in increased expression of GADD45G mRNA CTD PMID:19484750 17beta-estradiol affects expression ISO RGD:1323436 6480464 Estradiol affects the expression of GADD45G mRNA CTD PMID:22574217 17beta-estradiol affects expression ISO RGD:1323437 6480464 Estradiol affects the expression of GADD45G mRNA CTD PMID:15598610 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1323436 6480464 Dihydrotestosterone results in increased expression of GADD45G mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1323437 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1323437 6480464 [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GADD45G mRNA] more ... CTD PMID:16054899 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GADD45G mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GADD45G mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1323437 6480464 Tetrachlorodibenzodioxin results in decreased expression of GADD45G mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323437 6480464 Tetrachlorodibenzodioxin affects the expression of GADD45G mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323436 6480464 Tetrachlorodibenzodioxin affects the expression of GADD45G mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1323437 6480464 Tetrachlorodibenzodioxin results in increased expression of GADD45G mRNA CTD PMID:16054899 2-butoxyethanol increases expression ISO RGD:1323437 6480464 n-butoxyethanol results in increased expression of GADD45G mRNA CTD PMID:19812364 2-nitropropane increases expression ISO RGD:1323437 6480464 2-nitropropane results in increased expression of GADD45G mRNA CTD PMID:19268524 2-nitropropane multiple interactions ISO RGD:1323437 6480464 APEX1 protein inhibits the reaction [2-nitropropane results in increased expression of GADD45G mRNA] CTD PMID:19268524 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1323437 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GADD45G mRNA more ... CTD PMID:16054899 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1323437 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of GADD45G mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:1323437 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GADD45G mRNA CTD PMID:30951980 4-phenylcoumarin increases expression ISO RGD:1323437 6480464 4-phenylcoumarin analog results in increased expression of GADD45G mRNA CTD PMID:27773722 5-fluorouracil increases expression ISO RGD:1323437 6480464 Fluorouracil results in increased expression of GADD45G mRNA CTD PMID:19272435 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GADD45G mRNA CTD PMID:25825206 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of GADD45G mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1323436 6480464 Acrylamide results in increased expression of GADD45G mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1323436 6480464 Aflatoxin B1 results in increased expression of GADD45G mRNA CTD PMID:22100608 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GADD45G mRNA CTD PMID:33354967 aldehydo-D-glucose increases expression ISO RGD:1323437 6480464 Glucose results in increased expression of GADD45G mRNA CTD PMID:17178593 all-trans-retinoic acid decreases expression ISO RGD:1323436 6480464 Tretinoin results in decreased expression of GADD45G mRNA CTD PMID:23724009 amiodarone increases expression ISO RGD:1323436 6480464 Amiodarone results in increased expression of GADD45G mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GADD45G mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:1323436 6480464 aristolochic acid I results in increased expression of GADD45G mRNA CTD PMID:33212167 arsenic trichloride increases expression ISO RGD:1323437 6480464 arsenic trichloride results in increased expression of GADD45G mRNA CTD PMID:16283526 arsenic trichloride multiple interactions ISO RGD:1323437 6480464 IKBKB affects the reaction [arsenic trichloride results in increased expression of GADD45G mRNA] CTD PMID:16283526 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA CTD PMID:33854195 benzo[a]pyrene increases expression ISO RGD:1323437 6480464 Benzo(a)pyrene results in increased expression of GADD45G mRNA CTD PMID:21569818 benzo[a]pyrene increases methylation ISO RGD:1323436 6480464 Benzo(a)pyrene results in increased methylation of GADD45G exon CTD PMID:27901495 benzo[b]fluoranthene increases expression ISO RGD:1323437 6480464 benzo(b)fluoranthene results in increased expression of GADD45G mRNA CTD PMID:26377693 biphenyl-4-amine increases expression ISO RGD:1323436 6480464 4-biphenylamine results in increased expression of GADD45G mRNA CTD PMID:24857880 bis(2-chloroethyl) sulfide increases expression ISO RGD:1323436 6480464 Mustard Gas results in increased expression of GADD45G mRNA CTD PMID:33491125 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GADD45G promoter CTD PMID:23359474 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1323436 6480464 Diethylhexyl Phthalate results in increased expression of GADD45G mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1323437 6480464 Diethylhexyl Phthalate results in decreased expression of GADD45G mRNA CTD PMID:26219507 , PMID:27060630 bisphenol A increases expression ISO RGD:1323437 6480464 bisphenol A results in increased expression of GADD45G mRNA CTD PMID:20826375 bisphenol A increases methylation ISO RGD:1323436 6480464 bisphenol A results in increased methylation of GADD45G promoter CTD PMID:30352284 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GADD45G mRNA CTD PMID:30903817 , PMID:32145629 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GADD45G mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GADD45G promoter CTD PMID:23359474 bortezomib increases expression ISO RGD:1323436 6480464 Bortezomib results in increased expression of GADD45G mRNA CTD PMID:17898295 Brevetoxin B increases expression ISO RGD:1323436 6480464 brevetoxin 2 results in increased expression of GADD45G mRNA CTD PMID:20498034 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of GADD45G mRNA CTD PMID:32479839 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of GADD45G mRNA CTD PMID:24136188 butanal increases expression ISO RGD:1323436 6480464 butyraldehyde results in increased expression of GADD45G mRNA CTD PMID:26079696 cadmium atom affects expression ISO RGD:1323436 6480464 Cadmium affects the expression of GADD45G mRNA CTD PMID:22562489 cadmium atom multiple interactions ISO RGD:1323436 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GADD45G mRNA CTD PMID:31738976 cadmium dichloride increases expression ISO RGD:1323436 6480464 Cadmium Chloride results in increased expression of GADD45G mRNA CTD PMID:12160620 cadmium dichloride multiple interactions ISO RGD:1323436 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GADD45G mRNA CTD PMID:31738976 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GADD45G mRNA CTD PMID:19010381 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of GADD45G promoter CTD PMID:22457795 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of GADD45G mRNA CTD PMID:22110744 calcitriol multiple interactions ISO RGD:1323436 6480464 [salinomycin co-treated with Calcitriol] results in increased expression of GADD45G mRNA more ... CTD PMID:21592394 , PMID:35914560 calcitriol increases expression ISO RGD:1323436 6480464 Calcitriol results in increased expression of GADD45G mRNA CTD PMID:21592394 , PMID:35914560 camptothecin increases expression ISO RGD:1323436 6480464 Camptothecin results in increased expression of GADD45G mRNA CTD PMID:24792648 cannabidiol increases expression ISO RGD:1323436 6480464 Cannabidiol results in increased expression of GADD45G mRNA CTD PMID:36519830 captan decreases expression ISO RGD:1323437 6480464 Captan results in decreased expression of GADD45G mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1323436 6480464 Carbamazepine affects the expression of GADD45G mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1323437 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of GADD45G mRNA CTD PMID:19395590 CGP 52608 multiple interactions ISO RGD:1323436 6480464 CGP 52608 promotes the reaction [RORA protein binds to GADD45G gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1323437 6480464 Chlordecone results in increased expression of GADD45G mRNA CTD PMID:29980752 chloroprene increases expression ISO RGD:1323437 6480464 Chloroprene results in increased expression of GADD45G mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:1323437 6480464 Chlorpyrifos results in decreased expression of GADD45G mRNA CTD PMID:20350560 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA CTD PMID:33854195 cholesterol multiple interactions ISO RGD:1323437 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GADD45G mRNA CTD PMID:22129739 choline multiple interactions ISO RGD:1323437 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GADD45G mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GADD45G gene CTD PMID:20938992 , PMID:33549593 ciglitazone increases expression EXP 6480464 ciglitazone results in increased expression of GADD45G mRNA CTD PMID:22193206 ciguatoxin CTX1B affects expression ISO RGD:1323437 6480464 Ciguatoxins affects the expression of GADD45G mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of GADD45G mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:1323436 6480464 Cisplatin results in increased expression of GADD45G mRNA CTD PMID:33545341 clofibrate multiple interactions ISO RGD:1323437 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GADD45G mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GADD45G mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of GADD45G mRNA CTD PMID:22008536 clofibrate decreases expression ISO RGD:1323437 6480464 Clofibrate results in decreased expression of GADD45G mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1323437 6480464 cobaltous chloride results in decreased expression of GADD45G mRNA CTD PMID:21139344 copper atom multiple interactions ISO RGD:1323436 6480464 [NSC 689534 binds to Copper] which results in increased expression of GADD45G mRNA CTD PMID:20971185 copper atom decreases expression EXP 6480464 Copper results in decreased expression of GADD45G mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1323436 6480464 [NSC 689534 binds to Copper] which results in increased expression of GADD45G mRNA CTD PMID:20971185 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of GADD45G mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1323436 6480464 Copper Sulfate results in increased expression of GADD45G mRNA CTD PMID:19549813 CU-O LINKAGE increases expression ISO RGD:1323436 6480464 cupric oxide results in increased expression of GADD45G mRNA, cupric oxide results in increased expression of GADD45G protein CTD PMID:22077320 cyanocob(III)alamin multiple interactions ISO RGD:1323437 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GADD45G mRNA CTD PMID:33549593 cyclosporin A increases expression ISO RGD:1323436 6480464 Cyclosporine results in increased expression of GADD45G mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:1323437 6480464 Cyclosporine results in decreased expression of GADD45G mRNA CTD PMID:19770486 D-glucose increases expression ISO RGD:1323437 6480464 Glucose results in increased expression of GADD45G mRNA CTD PMID:17178593 dexamethasone multiple interactions ISO RGD:1323437 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GADD45G mRNA more ... CTD PMID:16054899 diazinon affects expression EXP 6480464 Diazinon affects the expression of GADD45G mRNA CTD PMID:22546817 dibutyl phthalate decreases expression ISO RGD:1323437 6480464 Dibutyl Phthalate results in decreased expression of GADD45G mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GADD45G promoter CTD PMID:23359474 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GADD45G mRNA CTD PMID:21266533 diclofenac increases expression ISO RGD:1323437 6480464 Diclofenac results in increased expression of GADD45G mRNA CTD PMID:26934552 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of GADD45G mRNA CTD PMID:22546817 diethyl maleate increases expression ISO RGD:1323436 6480464 diethyl maleate results in increased expression of GADD45G mRNA CTD PMID:33545341 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of GADD45G mRNA CTD PMID:21658437 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of GADD45G mRNA CTD PMID:22193206 dioxygen multiple interactions ISO RGD:1323437 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45G mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GADD45G mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:1323436 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GADD45G mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1323436 6480464 Doxorubicin results in increased expression of GADD45G mRNA CTD PMID:16404146 , PMID:36634904 doxorubicin multiple interactions ISO RGD:1323436 6480464 Doxorubicin promotes the reaction [NR1I3 protein results in increased expression of GADD45G mRNA] CTD PMID:21557330 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GADD45G mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1323437 6480464 epoxiconazole results in decreased expression of GADD45G mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:1323437 6480464 Ethanol results in decreased expression of GADD45G mRNA CTD PMID:19167417 ethanol decreases expression ISO RGD:1323436 6480464 Ethanol results in decreased expression of GADD45G mRNA CTD PMID:31059573 febuxostat increases expression ISO RGD:1323436 6480464 Febuxostat results in increased expression of GADD45G mRNA CTD PMID:35866629 fenpyroximate increases expression ISO RGD:1323436 6480464 fenpyroximate results in increased expression of GADD45G mRNA CTD PMID:33512557 fluoranthene decreases expression ISO RGD:1323437 6480464 fluoranthene results in decreased expression of GADD45G mRNA CTD PMID:28329830 fluoranthene multiple interactions ISO RGD:1323437 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of GADD45G mRNA, [1-methylanthracene co-treated with fluoranthene] results in increased expression of GADD45G mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:1323437 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GADD45G mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GADD45G gene CTD PMID:20938992 , PMID:33549593 folpet decreases expression ISO RGD:1323437 6480464 folpet results in decreased expression of GADD45G mRNA CTD PMID:31558096 fonofos increases methylation ISO RGD:1323436 6480464 Fonofos results in increased methylation of GADD45G promoter CTD PMID:22847954 furan decreases expression EXP 6480464 furan results in decreased expression of GADD45G mRNA CTD PMID:26194646 gefitinib decreases expression ISO RGD:1323436 6480464 gefitinib results in decreased expression of GADD45G mRNA CTD PMID:16685379 genistein increases expression ISO RGD:1323437 6480464 Genistein results in increased expression of GADD45G mRNA CTD PMID:24967385 genistein increases expression ISO RGD:1323436 6480464 Genistein results in increased expression of GADD45G mRNA CTD PMID:23019147 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of GADD45G mRNA CTD PMID:33387578 glucose increases expression ISO RGD:1323437 6480464 Glucose results in increased expression of GADD45G mRNA CTD PMID:17178593 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of GADD45G mRNA CTD PMID:24915197 glycine betaine multiple interactions ISO RGD:1323437 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GADD45G mRNA CTD PMID:33549593 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA CTD PMID:33854195 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of GADD45G mRNA CTD PMID:34850229 glyphosate increases expression ISO RGD:1323436 6480464 glyphosate results in increased expression of GADD45G mRNA CTD PMID:31295307 graphene oxide increases expression ISO RGD:1323437 6480464 graphene oxide analog results in increased expression of GADD45G mRNA CTD PMID:33227293 hydrogen cyanide increases expression ISO RGD:1323437 6480464 Hydrogen Cyanide results in increased expression of GADD45G mRNA CTD PMID:33914522 hydrogen sulfide increases expression ISO RGD:1323437 6480464 Hydrogen Sulfide results in increased expression of GADD45G mRNA CTD PMID:31843631 hypochlorous acid increases expression ISO RGD:1323437 6480464 Hypochlorous Acid results in increased expression of GADD45G mRNA CTD PMID:19376150 idarubicin multiple interactions ISO RGD:1323437 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in increased expression of GADD45G mRNA] CTD PMID:28973540 idarubicin increases expression ISO RGD:1323437 6480464 Idarubicin results in increased expression of GADD45G mRNA CTD PMID:28973540 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA CTD PMID:33854195 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45G mRNA CTD PMID:22129741 inulin multiple interactions ISO RGD:1323437 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GADD45G mRNA CTD PMID:36331819 irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of GADD45G mRNA CTD PMID:20097248 isoprenaline increases expression ISO RGD:1323437 6480464 Isoproterenol results in increased expression of GADD45G mRNA CTD PMID:21823215 kainic acid decreases expression ISO RGD:1323437 6480464 Kainic Acid results in decreased expression of GADD45G mRNA CTD PMID:17997037 L-methionine multiple interactions ISO RGD:1323437 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GADD45G mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GADD45G gene CTD PMID:20938992 , PMID:33549593 lead diacetate increases methylation EXP 6480464 lead acetate results in increased methylation of GADD45G gene CTD PMID:29571894 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GADD45G mRNA CTD PMID:19564919 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of GADD45G mRNA CTD PMID:19564919 methotrexate increases expression ISO RGD:1323436 6480464 Methotrexate results in increased expression of GADD45G mRNA CTD PMID:21678067 methoxychlor affects expression ISO RGD:1323437 6480464 Methoxychlor affects the expression of GADD45G mRNA CTD PMID:20829426 methylisothiazolinone increases expression ISO RGD:1323436 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of GADD45G mRNA CTD PMID:31629900 methylmercury chloride decreases expression ISO RGD:1323436 6480464 methylmercuric chloride results in decreased expression of GADD45G mRNA CTD PMID:28001369 methylmercury(1+) increases expression EXP 6480464 methylmercury II results in increased expression of GADD45G mRNA CTD PMID:17905399 miconazole increases expression ISO RGD:1323437 6480464 Miconazole results in increased expression of GADD45G mRNA CTD PMID:27462272 microcystin-LR decreases expression ISO RGD:1323437 6480464 cyanoginosin LR results in decreased expression of GADD45G mRNA CTD PMID:17383702 milrinone increases expression EXP 6480464 Milrinone results in increased expression of GADD45G mRNA CTD PMID:22936366 myristicin decreases expression ISO RGD:1323436 6480464 myristicin results in decreased expression of GADD45G mRNA CTD PMID:24792648 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45G mRNA CTD PMID:22129741 N-acetyl-L-cysteine multiple interactions ISO RGD:1323436 6480464 Acetylcysteine inhibits the reaction [[xanthatin results in increased expression of GADD45G mRNA] which results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:23313378 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1323437 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of GADD45G mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium increases expression ISO RGD:1323436 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GADD45G mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of GADD45G mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO RGD:1323437 6480464 Diethylnitrosamine results in increased expression of GADD45G mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45G mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions ISO RGD:1323437 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GADD45G mRNA] CTD PMID:17942915 neomycin increases expression ISO RGD:1323437 6480464 Neomycin results in increased expression of GADD45G mRNA CTD PMID:30626089 neomycin multiple interactions ISO RGD:1323437 6480464 Plant Oils inhibits the reaction [Neomycin results in increased expression of GADD45G mRNA] CTD PMID:30626089 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of GADD45G mRNA CTD PMID:22546817 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of GADD45G mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of GADD45G mRNA CTD PMID:26720608 , PMID:33484710 ochratoxin A decreases expression ISO RGD:1323436 6480464 ochratoxin A results in decreased expression of GADD45G mRNA CTD PMID:30763683 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of GADD45G mRNA CTD PMID:23665939 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GADD45G mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1323437 6480464 Ozone results in increased expression of GADD45G mRNA CTD PMID:19555225 ozone multiple interactions ISO RGD:1323437 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GADD45G mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GADD45G mRNA CTD PMID:34911549 panobinostat increases expression ISO RGD:1323436 6480464 panobinostat results in increased expression of GADD45G mRNA CTD PMID:23681230 panobinostat multiple interactions ISO RGD:1323436 6480464 GADD45G protein affects the susceptibility to [SRT2183 co-treated with panobinostat] more ... CTD PMID:23681230 paracetamol multiple interactions ISO RGD:1323437 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GADD45G mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GADD45G mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GADD45G mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1323437 6480464 Acetaminophen results in increased expression of GADD45G mRNA CTD PMID:29540258 paracetamol affects expression ISO RGD:1323437 6480464 Acetaminophen affects the expression of GADD45G mRNA CTD PMID:15606129 , PMID:17562736 paraquat increases expression ISO RGD:1323437 6480464 Paraquat results in increased expression of GADD45G mRNA CTD PMID:12595580 more ... parathion increases methylation ISO RGD:1323436 6480464 Parathion results in increased methylation of GADD45G promoter CTD PMID:22847954 pentanal increases expression ISO RGD:1323436 6480464 pentanal results in increased expression of GADD45G mRNA CTD PMID:26079696 perfluorononanoic acid increases expression ISO RGD:1323436 6480464 perfluoro-n-nonanoic acid results in increased expression of GADD45G mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1323436 6480464 perfluorooctane sulfonic acid results in decreased expression of GADD45G mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1323437 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GADD45G mRNA more ... CTD PMID:36331819 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of GADD45G mRNA CTD PMID:31324951 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of GADD45G mRNA CTD PMID:22008536 phenobarbital affects expression ISO RGD:1323437 6480464 Phenobarbital affects the expression of GADD45G mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1323436 6480464 Phenylmercuric Acetate results in increased expression of GADD45G mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1323436 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GADD45G mRNA CTD PMID:27188386 phosgene affects expression ISO RGD:1323437 6480464 Phosgene affects the expression of GADD45G mRNA CTD PMID:16300373 phosphoramide mustard increases expression EXP 6480464 phosphoramide mustard results in increased expression of GADD45G mRNA CTD PMID:26708502 pirinixic acid multiple interactions ISO RGD:1323437 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of GADD45G mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of GADD45G mRNA] CTD PMID:20059764 , PMID:20813756 pirinixic acid increases expression ISO RGD:1323437 6480464 pirinixic acid results in increased expression of GADD45G mRNA CTD PMID:16985257 more ... pirinixic acid decreases expression ISO RGD:1323437 6480464 pirinixic acid results in decreased expression of GADD45G mRNA CTD PMID:17426115 potassium cyanide increases expression ISO RGD:1323437 6480464 Potassium Cyanide results in increased expression of GADD45G mRNA CTD PMID:33914522 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1323437 6480464 Pregnenolone Carbonitrile results in increased expression of GADD45G mRNA CTD PMID:28903501 progesterone affects expression ISO RGD:1323437 6480464 Progesterone affects the expression of GADD45G mRNA CTD PMID:17251523 propanal increases expression ISO RGD:1323436 6480464 propionaldehyde results in increased expression of GADD45G mRNA CTD PMID:26079696 reactive oxygen species multiple interactions ISO RGD:1323436 6480464 [xanthatin results in increased expression of GADD45G mRNA] which results in increased abundance of Reactive Oxygen Species, Acetylcysteine inhibits the reaction [[xanthatin results in increased expression of GADD45G mRNA] which results in increased abundance of Reactive Oxygen Species] CTD PMID:23313378 resveratrol multiple interactions ISO RGD:1323436 6480464 panobinostat promotes the reaction [resveratrol inhibits the reaction [STAT3 protein binds to GADD45G promoter]] more ... CTD PMID:23681230 resveratrol multiple interactions ISO RGD:1323437 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of GADD45G mRNA] CTD PMID:31298478 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of GADD45G mRNA CTD PMID:33775663 resveratrol increases expression ISO RGD:1323436 6480464 resveratrol results in increased expression of GADD45G mRNA CTD PMID:23681230 ritodrine decreases expression ISO RGD:1323437 6480464 Ritodrine results in decreased expression of GADD45G mRNA CTD PMID:23370008 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of GADD45G mRNA CTD PMID:19013527 Salinomycin multiple interactions ISO RGD:1323436 6480464 [salinomycin co-treated with Calcitriol] results in increased expression of GADD45G mRNA CTD PMID:35914560 SB 431542 multiple interactions ISO RGD:1323436 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GADD45G mRNA CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of GADD45G mRNA CTD PMID:19564919 silicon dioxide increases expression ISO RGD:1323436 6480464 Silicon Dioxide results in increased expression of GADD45G mRNA CTD PMID:25351596 silicon dioxide increases expression ISO RGD:1323437 6480464 Silicon Dioxide results in increased expression of GADD45G mRNA CTD PMID:29341224 sodium arsenate decreases expression ISO RGD:1323437 6480464 sodium arsenate results in decreased expression of GADD45G mRNA CTD PMID:21795629 sodium arsenate increases expression ISO RGD:1323437 6480464 sodium arsenate results in increased expression of GADD45G mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1323436 6480464 sodium arsenite results in increased expression of GADD45G mRNA CTD PMID:26535918 sodium arsenite decreases expression ISO RGD:1323437 6480464 sodium arsenite results in decreased expression of GADD45G mRNA CTD PMID:16014739 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of GADD45G mRNA CTD PMID:22561333 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of GADD45G mRNA CTD PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of GADD45G mRNA CTD PMID:19281266 sorafenib decreases response to substance ISO RGD:1323436 6480464 GADD45G mutant form results in decreased susceptibility to sorafenib CTD PMID:26172295 sorafenib increases expression ISO RGD:1323436 6480464 sorafenib results in increased expression of GADD45G mRNA, sorafenib results in increased expression of GADD45G protein CTD PMID:26172295 sorafenib multiple interactions ISO RGD:1323436 6480464 sorafenib promotes the reaction [CEBPD protein binds to GADD45G promoter] CTD PMID:26172295 sunitinib decreases expression ISO RGD:1323436 6480464 Sunitinib results in decreased expression of GADD45G mRNA CTD PMID:31533062 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of GADD45G mRNA CTD PMID:26141394 tamoxifen affects expression ISO RGD:1323437 6480464 Tamoxifen affects the expression of GADD45G mRNA CTD PMID:17555576 , PMID:20937368 terbufos increases methylation ISO RGD:1323436 6480464 terbufos results in increased methylation of GADD45G promoter CTD PMID:22847954 testosterone multiple interactions ISO RGD:1323436 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GADD45G mRNA more ... CTD PMID:21592394 testosterone increases expression ISO RGD:1323437 6480464 Testosterone results in increased expression of GADD45G mRNA CTD PMID:21669218 testosterone affects expression ISO RGD:1323437 6480464 Testosterone affects the expression of GADD45G mRNA CTD PMID:20403060 testosterone increases expression ISO RGD:1323436 6480464 Testosterone results in increased expression of GADD45G mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1323437 6480464 Carbon Tetrachloride results in increased expression of GADD45G mRNA CTD PMID:27339419 , PMID:31919559 tetraphene decreases expression ISO RGD:1323437 6480464 benz(a)anthracene results in decreased expression of GADD45G mRNA CTD PMID:26377693 thapsigargin increases expression ISO RGD:1323436 6480464 Thapsigargin results in increased expression of GADD45G mRNA CTD PMID:29453283 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA CTD PMID:33854195 thimerosal increases expression ISO RGD:1323436 6480464 Thimerosal results in increased expression of GADD45G mRNA CTD PMID:16870260 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of GADD45G mRNA CTD PMID:23411599 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GADD45G mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:1323437 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of GADD45G mRNA] CTD PMID:31298478 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of GADD45G mRNA CTD PMID:30012374 titanium dioxide increases expression ISO RGD:1323437 6480464 titanium dioxide results in increased expression of GADD45G mRNA CTD PMID:23557971 more ... topotecan increases expression EXP 6480464 Topotecan results in increased expression of GADD45G mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GADD45G mRNA CTD PMID:25729387 tributylstannane decreases expression ISO RGD:1323437 6480464 tributyltin results in decreased expression of GADD45G mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GADD45G mRNA CTD PMID:33387578 triclosan increases expression ISO RGD:1323436 6480464 Triclosan results in increased expression of GADD45G mRNA CTD PMID:30510588 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of GADD45G mRNA CTD PMID:23639586 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of GADD45G mRNA CTD PMID:24136188 trovafloxacin increases expression ISO RGD:1323437 6480464 trovafloxacin results in increased expression of GADD45G mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:1323436 6480464 Tunicamycin results in increased expression of GADD45G mRNA CTD PMID:29453283 , PMID:33545341 valproic acid decreases expression ISO RGD:1323437 6480464 Valproic Acid results in decreased expression of GADD45G mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:1323436 6480464 Valproic Acid results in increased expression of GADD45G mRNA CTD PMID:23179753 valproic acid decreases expression ISO RGD:1323436 6480464 Valproic Acid results in decreased expression of GADD45G mRNA CTD PMID:24383497 vincaleukoblastine increases expression EXP 6480464 Vinblastine results in increased expression of GADD45G mRNA CTD PMID:20624997 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of GADD45G mRNA CTD PMID:23555832 vincristine increases expression EXP 6480464 Vincristine results in increased expression of GADD45G mRNA CTD PMID:20624997 Xanthatin multiple interactions ISO RGD:1323436 6480464 [xanthatin results in decreased expression of TOP2A] which results in increased expression of GADD45G mRNA more ... CTD PMID:23313378 , PMID:23824011 Xanthatin increases expression ISO RGD:1323436 6480464 xanthatin results in increased expression of GADD45G mRNA, xanthatin results in increased expression of GADD45G protein CTD PMID:21568272 more ... zinc atom multiple interactions ISO RGD:1323437 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GADD45G mRNA CTD PMID:33549593 zinc(0) multiple interactions ISO RGD:1323437 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of GADD45G mRNA CTD PMID:33549593 zoledronic acid increases expression ISO RGD:1323436 6480464 zoledronic acid results in increased expression of GADD45G mRNA CTD PMID:24714768